Leading Korean drugmakers in race for larger market share

Major leading pharmaceutical manufacturers are vying for a bigger share in the local drug market, expanding their presence.

Green Cross Corporation is expected to see its sales further rise in the fourth quarter when it will supply H1N1 flu vaccines, which may make the company the No. 2 drug firm on an annual basis.

Green Cross posted revenues of 159 billion won in the third quarter, whi...